The human retrovirus human T-lymphotropic virus type 1 (HTLV-1) is associated with two distinct types of disease: the malignancy known as adult T-cell leukemia and a range of chronic inflammatory conditions including the central nervous system disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Until recently, it was believed that HTLV-1 was largely latent in vivo. However, evidence from a number of types of experiments shows that HTLV-1 persistently expresses its genes, and that the “set point” of an individual’s proviral load of HTLV-1 is mainly determined by the efficiency of that individual’s cellular immune response to the virus.These conclusions have two main consequences. First, HTLV-1 may be vulnerable to antiretroviral drug therapy or immunotherapy. Second, HTLV-1 infection has become a useful system to analyze the determinants of the efficiency of the antiviral immune response. Society of Hematology
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Green PL, Chen ISY. Human T lymphotropic viruses types 1 and 2. In Knipe, DM, Howley PM, eds,Fields Virology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2001:1941–1969.
Hollsberg P. Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.Microbiol Mol Biol Rev. 1999;63:308–333.
Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.Annu Rev Immunol. 2001;19:475–496.
Johnson JM, Harrod R, Franchini G. Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).Int J Exp Pathol. 2001;82:135–147.
Albrecht B, Lairmore MD. Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis.Microbiol Mol Biol Rev. 2002;66:396–406, Table of contents.
Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases.Annu Rev Immunol. 1997;15:15–37.
Watanabe T. HTLV-1-associated diseases.Int J Hematol. 1997;66:257–278.
Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.Lancet. 1985;2:407–410.
Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity.Lancet. 1986;1:1031–1032.
Nakagawa M, Izumo S, Ijichi S, et al. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings.J Neurovirol. 1995;1:50–61.
Mochizuki M, Watanabe T, Yamaguchi K, et al. Uveitis associated with human T lymphotropic virus type I: seroepidemiologic, clinical, and virologic studies.J Infect Dis. 1992;166:943–944.
Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica.Lancet. 1989;2:1184–1187.
LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection.Lancet. 1990;336:1345–1347.
Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I.Lancet. 1989;1:441.
Hanon E, Stinchcombe JC, Saito M, et al. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I.Immunity. 2000;13:657–664.
Nagai M, Brennan MB, Sakai JA, Mora CA, Jacobson S. CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I.Blood. 2001;98:1858–1861.
Lehky TJ, Fox CH, Koenig S, et al. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization.Ann Neurol. 1995;37:167–175.
Matsuoka E, Takenouchi N, Hashimoto K, et al. Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy/tropical spastic paraparesis: double staining of immunohistochemistry and polymerase chain reaction in situ hybridization.Acta Neuropathol (Berl). 1998;96:340–346.
Southern SO, Southern PJ. Persistent HTLV-I infection of breast luminal epithelial cells: a role in HTLV transmission?Virology. 1998;241:200–214.
Ijichi S, Izumo S, Eiraku N, et al. An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP.Med Hypotheses. 1993;41:542–547.
Daenke S, Bangham CR. Do T cells cause HTLV-1-associated disease? A taxing problem.Clin Exp Immunol. 1994;96:179–181.
Yoshida M, Osame M, Kawai H, et al. Increased replication of HTLV-I in HTLV-I-associated myelopathy.Ann Neurol. 1989;26:331–335.
Gessain A, Saal F, Gout O, et al. High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis.Blood. 1990;75:428–433.
Kira J, Koyanagi Y, Yamada T, et al. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study.Ann Neurol. 1991;29:194–201.
Kubota R, Fujiyoshi T, Izumo S, et al. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy.J Neuroimmunol. 1993;42:147–154.
Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP.J Neurovirol. 1998;4:586–593.
Matsuzaki T, Nakagawa M, Nagai M, et al. HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years.J Neurovirol. 2001;7:228–234.
Taylor GP, Tosswill JH, Matutes E, et al. Prospective study of HTLV-I infection in an initially asymptomatic cohort.J Acquir Immune Defic Syndr. 1999;22:92–100.
Manns A, Miley WJ, Wilks RJ, et al. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection.J Infect Dis. 1999;180:1487–1493.
Daenke S, Nightingale S, Cruickshank JK, Bangham CR. Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates.J Virol. 1990;64:1278–1282.
Bangham CR. The immune response to HTLV-I.Curr Opin Immunol. 2000;12:397–402.
Slattery JP, Franchini G, Gessain A. Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses.Genome Res. 1999;9:525–540.
Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M, Osame M. Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis.J Infect Dis. 2000;182:1343–1349.
Taylor GP, Hall SE, Navarrete S, et al. Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy.J Virol. 1999;73:10289–10295.
Bangham CRM. The immune control and cell to cell spread of HTLV-1.J Gen Virol. In press.
Jacobson S. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease.J Infect Dis. 2002;186(suppl 2):S187-S192.
Yu F, Itoyama Y, Fujihara K, Goto I. Natural killer (NK) cells in HTLV-I-associated myelopathy/tropical spastic paraparesisdecrease in NK cell subset populations and activity in HTLV-I seropositive individuals.J Neuroimmunol. 1991;33:121–128.
Saito M, Braud VM, Goon P, et al. Low frequency of CD94/ NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.Blood. 2003;102:577–584.
McMichael AJ. Principles of immunology. In: Warrell DA, Cox TM, Firth JD, Benz EJ, eds,Oxford Textbook of Medicine. 4th ed. Oxford: Oxford University Press; 2003:131–144.
Umehara F, Izumo S, Nakagawa M, et al. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLVI-associated myelopathy.J Neuropathol Exp Neurol. 1993;52:424–430.
Iwasaki Y, Ohara Y, Kobayashi I, Akizuki S. Infiltration of helper/ inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection.Am J Pathol. 1992;140:1003–1008.
Niewiesk S, Daenke S, Parker CE, et al. The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis.J Virol. 1994;68:6778–6781.
Bangham CRM, Kermode AG, Hall SE, Daenke S. The cytotoxic T-lymphocyte response to HTLV-I: the main determinant of disease?Semin Virol. 1996;7:41–48.
Nowak MA, Bangham CR. Population dynamics of immune responses to persistent viruses.Science. 1996;272:74–79.
Jeffery KJ, Usuku K, Hall SE, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.Proc Natl Acad Sci U S A. 1999;96:3848–3853.
Jeffery KJ, Siddiqui AA, Bunce M, et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.J Immunol. 2000;165:7278–7284.
Vine AM, Witkover AD, Lloyd AL, et al. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.J Infect Dis. 2002;186:932–939.
Cavrois M, Gessain A, Wain-Hobson S, Wattel E. Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM.Oncogene. 1996;12:2419–2423.
Asquith B, Bangham CR. An introduction to lymphocyte and viral dynamics: the power and limitations of mathematical analysis.Proc R Soc Lond B Biol Sci. 2003;270:1651–1657.
Asquith B, Bangham CR. The dynamics of T-cell fratricide: application of a robust approach to mathematical modelling in immunology.J Theor Biol. 2003;222:53–69.
Okochi K, Sato H. Transmission of ATLV (HTLV-I) through blood transfusion.Princess Takamatsu Symp. 1984;15:129–135.
Popovic M, Sarin PS, Robert-Gurroff M, et al. Isolation and trans mission of human retrovirus (human t-cell leukemia virus).Science. 1983;219:856–859.
Yamamoto N, Okada M, Koyanagi Y, Kannagi M, Hinuma Y. Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line.Science. 1982;217:737–739.
Fan N, Gavalchin J, Paul B, Wells KH, Lane MJ, Poiesz BJ. Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lymphoma/leukemia virus type I.J Clin Microbiol. 1992;30:905–910.
Goon PKC, Hanon E, Igakura T, et al. High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.Blood. 2002;99:3335–3341.
Grakoui A, Bromley SK, Sumen C, et al. The immunological synapse: a molecular machine controlling T cell activation.Science. 1999;285:221–227.
Igakura T, Stinchcombe JC, Goon PK, et al. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton.Science. 2003;299:1713–1716.
Schick P, Trepel F, Eder M, et al. Autotransfusion of 3H-cytidinelabelled blood lymphocytes in patients with Hodgkin’s disease and non-Hodgkin patients, II: exchangeable lymphocyte pools.Acta Haematol. 1975;53:206–218.
Pabst R, Binns RM, Rothkotter HJ, Westermann J. Quantitative analysis of lymphocyte fluxes in vivo.Curr Top Microbiol Immunol. 1993;184:151–159.
Westermann J, Persin S, Matyas J, van der Meide P, Pabst R. IFNgamma influences the migration of thoracic duct B and T lymphocyte subsets in vivo. Random increase in disappearance from the blood and differential decrease in reappearance in the lymph.J Immunol. 1993;150:3843–3852.
Westermann J, Puskas Z, Pabst R. Blood transit and recirculation kinetics of lymphocyte subsets in normal rats.Scand J Immunol. 1988;28:203–210.
Ford WL. Lymphocyte migration and immune responses.Prog Allergy. 1975;19:1–59.
Moritoyo T, Izumo S, Moritoyo H, et al. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.J Neurovirol. 1999;5:241–248.
Hanon E, Hall S, Taylor GP, et al. Abundant tax protein expression in CD4+ T cells infected with human T- cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.Blood. 2000;95:1386–1392.
Debacq C, Asquith B, Kerkhofs P, et al. Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep.Proc Natl Acad Sci U S A. 2002;99:10048–10053.
Asquith B, Debacq C, Macallan DC, Willems L, Bangham CR. Lymphocyte kinetics: the interpretation of labelling data.Trends Immunol. 2002;23:596–601.
Macallan DC, Asquith B, Irvine AJ, et al. Measurement and modeling of human T cell kinetics.Eur J Immunol. 2003;33:2316–2326.
Macallan DC, Fullerton CA, Neese RA, Haddock K, Park SS, Hellerstein MK. Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: studies in vitro, in animals, and in humans.Proc Natl Acad Sci U S A. 1998;95:708–713.
Mohri H, Perelson AS, Tung K, et al. Increased turnover of T lym lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy.J Exp Med. 2001;194:1277–1287.
Levin MC, Lee SM, Kalume F, et al. Autoimmunity due to molecular mimicry as a cause of neurological disease.Nat Med. 2002;8:509–513.
Goon PK, Igakura T, Hanon E, et al. High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.J Virol. 2003;77:9716–9722.
Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.Nature. 1990;348:245–248.
Parker CE, Daenke S, Nightingale S, Bangham CR. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis.Virology. 1992;188:628–636.
Parker CE, Nightingale S, Taylor GP, Weber J, Bangham CR. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously.J Virol. 1994;68:2860–2868.
Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, Jacobson S. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.J Exp Med. 1993;177:1567–1573.
Bieganowska K, Hollsberg P, Buckle GJ, et al. Direct analysis of viral-specific CD8+ T cells with soluble HLA- A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy.J Immunol. 1999;162:1765–1771.
Daenke S, Kermode AG, Hall SE, et al. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis.Virology. 1996;217:139–146.
Kannagi M, Harada S, Maruyama I, et al. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV- I-infected cells.Int Immunol. 1991;3:761–767.
Pique C, Ureta-Vidal A, Gessain A, et al. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides.J Exp Med. 2000;191:567–572.
Ishihara S, Okayama A, Stuver S, et al. Association of HTLV-I antibody profile of asymptomatic carriers with proviral DNA levels of peripheral blood mononuclear cells.J Acquir Immune Defic Syndr. 1994;7:199–203.
Kira J, Nakamura M, Sawada T, et al. Antibody titers to HTLV-Ip40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load.J Neurol Sci. 1992;107:98–104.
Nagasato K, Nakamura T, Shirabe S, et al. Presence of serum antihuman T-lymphotropic virus type I (HTLV-I) IgM antibodies means persistent active replication of HTLV-I in HTLV-I-associated myelopathy.J Neurol Sci. 1991;103:203–208.
Niewiesk S, Daenke S, Parker CE, et al. Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax.J Virol. 1995;69:2649–2653.
About this article
Cite this article
Bangham, C.R.M. Human T-Lymphotropic Virus Type 1 (HTLV-1): Persistence and Immune Control. Int J Hematol 78, 297–303 (2003). https://doi.org/10.1007/BF02983553
- Leukemia virus
- Immune response
- Cytotoxic T-Lymphocyte